{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:25:38Z","timestamp":1784157938692,"version":"3.55.0"},"reference-count":114,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary vascular remodeling leading to right heart failure and death. To date, despite the three therapeutic approaches targeting the three major endothelial dysfunction pathways based on the prostacyclin, nitric oxide\/cyclic guanosine monophosphate, and endothelin pathways, PAH remains a serious disease. As such, new targets and therapeutic agents are needed. Mitochondrial metabolic dysfunction is one of the mechanisms involved in PAH pathogenesis in part through the induction of a Warburg metabolic state of enhanced glycolysis but also through the upregulation of glutaminolysis, tricarboxylic cycle and electron transport chain dysfunction, dysregulation of fatty acid oxidation or mitochondrial dynamics alterations. The aim of this review is to shed light on the main mitochondrial metabolic pathways involved in PAH and to provide an update on the resulting interesting potential therapeutic perspectives.<\/jats:p>","DOI":"10.3390\/ijms24119572","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T03:06:00Z","timestamp":1685588760000},"page":"9572","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?"],"prefix":"10.3390","volume":"24","author":[{"given":"Marianne","family":"Riou","sequence":"first","affiliation":[{"name":"Translational Medicine Federation of Strasbourg (FMTS), CRBS, University of Strasbourg, Team 3072 \u201cMitochondria, Oxidative Stress and Muscle Protection\u201d, 1 Rue Eug\u00e8ne Boeckel, CS 60026, CEDEX 67084 Strasbourg, France"},{"name":"Physiology and Functional Exploration Unit, University Hospital of Strasbourg, 1 Place de l\u2019H\u00f4pital, CEDEX 67091 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Enache","sequence":"additional","affiliation":[{"name":"Translational Medicine Federation of Strasbourg (FMTS), CRBS, University of Strasbourg, Team 3072 \u201cMitochondria, Oxidative Stress and Muscle Protection\u201d, 1 Rue Eug\u00e8ne Boeckel, CS 60026, CEDEX 67084 Strasbourg, France"},{"name":"Physiology and Functional Exploration Unit, University Hospital of Strasbourg, 1 Place de l\u2019H\u00f4pital, CEDEX 67091 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Sauer","sequence":"additional","affiliation":[{"name":"Translational Medicine Federation of Strasbourg (FMTS), CRBS, University of Strasbourg, Team 3072 \u201cMitochondria, Oxidative Stress and Muscle Protection\u201d, 1 Rue Eug\u00e8ne Boeckel, CS 60026, CEDEX 67084 Strasbourg, France"},{"name":"Cardiology Unit, University Hospital of Strasbourg, 1 Place de l\u2019H\u00f4pital, CEDEX 67091 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3557-2642","authenticated-orcid":false,"given":"Anne-Laure","family":"Charles","sequence":"additional","affiliation":[{"name":"Translational Medicine Federation of Strasbourg (FMTS), CRBS, University of Strasbourg, Team 3072 \u201cMitochondria, Oxidative Stress and Muscle Protection\u201d, 1 Rue Eug\u00e8ne Boeckel, CS 60026, CEDEX 67084 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Geny","sequence":"additional","affiliation":[{"name":"Translational Medicine Federation of Strasbourg (FMTS), CRBS, University of Strasbourg, Team 3072 \u201cMitochondria, Oxidative Stress and Muscle Protection\u201d, 1 Rue Eug\u00e8ne Boeckel, CS 60026, CEDEX 67084 Strasbourg, France"},{"name":"Physiology and Functional Exploration Unit, University Hospital of Strasbourg, 1 Place de l\u2019H\u00f4pital, CEDEX 67091 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"ref_1","first-page":"2200879","article-title":"2022 ESC\/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and Pathobiology of Pulmonary Hypertension: State of the Art and Research Perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1105565","DOI":"10.3389\/fcell.2023.1105565","article-title":"Acquired Disorders of Mitochondrial Metabolism and Dynamics in Pulmonary Arterial Hypertension","volume":"11","author":"Breault","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2014.08.012","article-title":"Mitochondria: Roles in Pulmonary Hypertension","volume":"55","author":"Khoyrattee","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCRESAHA.115.301130","article-title":"The Metabolic Theory of Pulmonary Arterial Hypertension","volume":"115","author":"Paulin","year":"2014","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cmet.2014.01.004","article-title":"The Metabolic Basis of Pulmonary Arterial Hypertension","volume":"19","author":"Sutendra","year":"2014","journal-title":"Cell Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00109-010-0670-x","article-title":"The Role of Mitochondria in Pulmonary Vascular Remodeling","volume":"88","author":"Dromparis","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1073\/pnas.0605080104","article-title":"Alterations of Cellular Bioenergetics in Pulmonary Artery Endothelial Cells","volume":"104","author":"Xu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/BF01504608","article-title":"\u00dcber Den Stoffwechsel Der Carcinomzelle","volume":"12","author":"Warburg","year":"1924","journal-title":"Naturwissenschaften"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zeidan, E.M., Hossain, M.A., El-Daly, M., Abourehab, M.A.S., Khalifa, M.M.A., and Taye, A. (2022). Mitochondrial Regulation of the Hypoxia-Inducible Factor in the Development of Pulmonary Hypertension. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175219"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1091\/mbc.e10-01-0025","article-title":"Hypoxia-Inducible Factor-1 Activation in Nonhypoxic Conditions: The Essential Role of Mitochondrial-Derived Reactive Oxygen Species","volume":"21","author":"Patten","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-Inducible Factor-1alpha during Hypoxia: A Mechanism of O2 Sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential Roles of Hypoxia-Inducible Factor 1alpha (HIF-1alpha) and HIF-2alpha in Hypoxic Gene Regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.117.031655","article-title":"Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension","volume":"136","author":"Archer","year":"2017","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.117.028034","article-title":"Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2","volume":"136","author":"Caruso","year":"2017","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/CIRCULATIONAHA.117.028069","article-title":"Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124\/PTBP1 (Polypyrimidine Tract Binding Protein 1)\/Pyruvate Kinase Muscle Axis","volume":"136","author":"Zhang","year":"2017","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/rccm.201108-1562OC","article-title":"Lung 18F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Pulmonary Arterial Hypertension","volume":"185","author":"Marsboom","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/ehjci\/jev136","article-title":"Shifts in Myocardial Fatty Acid and Glucose Metabolism in Pulmonary Arterial Hypertension: A Potential Mechanism for a Maladaptive Right Ventricular Response","volume":"17","author":"Ohira","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","article-title":"The Right Ventricle in Pulmonary Arterial Hypertension: Disorders of Metabolism, Angiogenesis and Adrenergic Signaling in Right Ventricular Failure","volume":"115","author":"Ryan","year":"2014","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cphy.c190027","article-title":"Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Compr. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCULATIONAHA.116.024602","article-title":"Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension","volume":"135","author":"Rhodes","year":"2017","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Peng, J., Lu, C., Hsin, M., Mura, M., Wu, L., Chu, L., Zamel, R., Machuca, T., and Waddell, T. (2014). Metabolomic Heterogeneity of Pulmonary Arterial Hypertension. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088727"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"18623","DOI":"10.1038\/s41598-019-55053-6","article-title":"Integrative Proteomics and Phosphoproteomics in Pulmonary Arterial Hypertension","volume":"9","author":"Xu","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"667446","DOI":"10.3389\/fcvm.2021.667446","article-title":"Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension","volume":"8","author":"Mprah","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/690236","article-title":"Dysfunctional BMPR2 Signaling Drives an Abnormal Endothelial Requirement for Glutamine in Pulmonary Arterial Hypertension","volume":"7","author":"Egnatchik","year":"2017","journal-title":"Pulm. Circ."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00109-013-1064-7","article-title":"Cardiac Glutaminolysis: A Maladaptive Cancer Metabolism Pathway in the Right Ventricle in Pulmonary Hypertension","volume":"91","author":"Piao","year":"2013","journal-title":"J. Mol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1172\/JCI86387","article-title":"Vascular Stiffness Mechanoactivates YAP\/TAZ-Dependent Glutaminolysis to Drive Pulmonary Hypertension","volume":"126","author":"Bertero","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.240550002","article-title":"Glucose Fatty Acid Interactions and the Regulation of Glucose Disposal","volume":"55","author":"Randle","year":"1994","journal-title":"J. Cell. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0008-6363(96)00245-3","article-title":"Regulation of Myocardial Carbohydrate Metabolism under Normal and Ischaemic Conditions. Potential for Pharmacological Interventions","volume":"33","author":"Stanley","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/2045-8932.109960","article-title":"Metabolism and Bioenergetics in the Right Ventricle and Pulmonary Vasculature in Pulmonary Hypertension","volume":"3","author":"Archer","year":"2013","journal-title":"Pulm. Circ."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.115.019351","article-title":"Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension","volume":"133","author":"Brittain","year":"2016","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.201306-1086OC","article-title":"Evidence for Right Ventricular Lipotoxicity in Heritable Pulmonary Arterial Hypertension","volume":"189","author":"Hemnes","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/rccm.201507-1444OC","article-title":"Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle","volume":"194","author":"Talati","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_34","first-page":"1676","article-title":"Impaired Regional Fatty Acid Uptake and Systolic Dysfunction in Hypertrophied Right Ventricle","volume":"39","author":"Nagaya","year":"1998","journal-title":"J. Nucl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF03164765","article-title":"Detection of Impaired Fatty Acid Metabolism in Right Ventricular Hypertrophy: Assessment by I-123 Beta-Methyl Iodophenyl Pentadecanoic Acid (BMIPP) Myocardial Single-Photon Emission Computed Tomography","volume":"11","author":"Kim","year":"1997","journal-title":"Ann. Nucl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1111\/jcmm.14937","article-title":"Metabolomics Reveals Metabolite Changes of Patients with Pulmonary Arterial Hypertension in China","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mylonis, I., Simos, G., and Paraskeva, E. (2019). Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism. Cells, 8.","DOI":"10.3390\/cells8030214"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2009.05.005","article-title":"Activation of a HIF1alpha-PPARgamma Axis Underlies the Integration of Glycolytic and Lipid Anabolic Pathways in Pathologic Cardiac Hypertrophy","volume":"9","author":"Krishnan","year":"2009","journal-title":"Cell Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41598-019-57200-5","article-title":"Stable Isotope Metabolomics of Pulmonary Artery Smooth Muscle and Endothelial Cells in Pulmonary Hypertension and with TGF-Beta Treatment","volume":"10","author":"Sanders","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11010-018-3480-z","article-title":"CPT1 Regulates the Proliferation of Pulmonary Artery Smooth Muscle Cells through the AMPK-P53-P21 Pathway in Pulmonary Arterial Hypertension","volume":"455","author":"Zhuang","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"44ra58","DOI":"10.1126\/scitranslmed.3001327","article-title":"Fatty Acid Oxidation and Malonyl-CoA Decarboxylase in the Vascular Remodeling of Pulmonary Hypertension","volume":"2","author":"Sutendra","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1095-6433(02)00005-3","article-title":"Heart and Breast Muscle Mitochondrial Dysfunction in Pulmonary Hypertension Syndrome in Broilers (Gallus domesticus)","volume":"132","author":"Tang","year":"2002","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12931-018-0776-1","article-title":"Recurrent Inhibition of Mitochondrial Complex III Induces Chronic Pulmonary Vasoconstriction and Glycolytic Switch in the Rat Lung","volume":"19","author":"Rafikova","year":"2018","journal-title":"Respir. Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"James, J., Valuparampil Varghese, M., Vasilyev, M., Langlais, P.R., Tofovic, S.P., Rafikova, O., and Rafikov, R. (2020). Complex III Inhibition-Induced Pulmonary Hypertension Affects the Mitochondrial Proteomic Landscape. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165683"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cardiores.2007.05.012","article-title":"Right-Ventricular Failure Is Associated with Increased Mitochondrial Complex II Activity and Production of Reactive Oxygen Species","volume":"75","author":"Redout","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"H200","DOI":"10.1152\/ajpheart.00893.2008","article-title":"Endothelin Receptor Blockade Combined with Phosphodiesterase-5 Inhibition Increases Right Ventricular Mitochondrial Capacity in Pulmonary Arterial Hypertension","volume":"297","author":"Mouchaers","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.redox.2015.07.016","article-title":"Complex I Dysfunction Underlies the Glycolytic Switch in Pulmonary Hypertensive Smooth Muscle Cells","volume":"6","author":"Rafikov","year":"2015","journal-title":"Redox Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11010-012-1485-6","article-title":"Skeletal Muscle Mitochondrial Dysfunction Precedes Right Ventricular Impairment in Experimental Pulmonary Hypertension","volume":"373","author":"Enache","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Riou, M., Pizzimenti, M., Enache, I., Charloux, A., Canuet, M., Andres, E., Talha, S., Meyer, A., and Geny, B. (2020). Skeletal and Respiratory Muscle Dysfunctions in Pulmonary Arterial Hypertension. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020410"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e91415","DOI":"10.1172\/jci.insight.91415","article-title":"Platelets from Pulmonary Hypertension Patients Show Increased Mitochondrial Reserve Capacity","volume":"2","author":"Nguyen","year":"2017","journal-title":"JCI Insight"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Sommer, N., Theine, F.F., Pak, O., Tello, K., Richter, M., Gall, H., Wilhelm, J., Savai, R., Weissmann, N., and Seeger, W. (2022). Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension. J. Clin. Med., 11.","DOI":"10.3390\/jcm11144132"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Riou, M., Alfatni, A., Charles, A.-L., Andres, E., Pistea, C., Charloux, A., and Geny, B. (2020). New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051253"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1165\/rcmb.2012-0361OC","article-title":"Mitochondrial Hyperpolarization in Pulmonary Vascular Remodeling. Mitochondrial Uncoupling Protein Deficiency as Disease Model","volume":"49","author":"Pak","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e21620","DOI":"10.1096\/fj.202100067R","article-title":"Mitochondrial Fusion and Fission: The Fine-Tune Balance for Cellular Homeostasis","volume":"35","author":"Adebayo","year":"2021","journal-title":"FASEB J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"L1233","DOI":"10.1152\/ajplung.00356.2015","article-title":"Suppression of Endothelial PGC-1\u03b1 Is Associated with Hypoxia-Induced Endothelial Dysfunction and Provides a New Therapeutic Target in Pulmonary Arterial Hypertension","volume":"310","author":"Ye","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/j.bbadis.2017.07.018","article-title":"Inhibition of Mitochondrial Fission Prevents Hypoxia-Induced Metabolic Shift and Cellular Proliferation of Pulmonary Arterial Smooth Muscle Cells","volume":"1863","author":"Parra","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fphys.2018.00828","article-title":"Increased Drp1-Mediated Mitochondrial Fission Promotes Proliferation and Collagen Production by Right Ventricular Fibroblasts in Experimental Pulmonary Arterial Hypertension","volume":"9","author":"Tian","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"913904","DOI":"10.3389\/fcell.2022.913904","article-title":"Inhibitors of Mitochondrial Dynamics Mediated by Dynamin-Related Protein 1 in Pulmonary Arterial Hypertension","volume":"10","author":"Xiao","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.embor.7401062","article-title":"Reversible Phosphorylation of Drp1 by Cyclic AMP-Dependent Protein Kinase and Calcineurin Regulates Mitochondrial Fission and Cell Death","volume":"8","author":"Cribbs","year":"2007","journal-title":"EMBO Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"21583","DOI":"10.1074\/jbc.C700083200","article-title":"Cyclic AMP-Dependent Protein Kinase Phosphorylation of Drp1 Regulates Its GTPase Activity and Mitochondrial Morphology","volume":"282","author":"Chang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.molcel.2015.01.002","article-title":"Erk2 Phosphorylation of Drp1 Promotes Mitochondrial Fission and MAPK-Driven Tumor Growth","volume":"57","author":"Kashatus","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11124","DOI":"10.1038\/ncomms11124","article-title":"Early ERK1\/2 Activation Promotes DRP1-Dependent Mitochondrial Fission Necessary for Cell Reprogramming","volume":"7","author":"Prieto","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCRESAHA.111.263848","article-title":"Dynamin-Related Protein 1-Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension","volume":"110","author":"Marsboom","year":"2012","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.devcel.2017.02.020","article-title":"The Putative Drp1 Inhibitor Mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor That Modulates Reactive Oxygen Species","volume":"40","author":"Bordt","year":"2017","journal-title":"Dev. Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/CIRCULATIONAHA.117.031258","article-title":"Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications","volume":"138","author":"Chen","year":"2018","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2017.05.003","article-title":"Epigallocatechin-3-Gallate Ameliorates Hypoxia-Induced Pulmonary Vascular Remodeling by Promoting Mitofusin-2-Mediated Mitochondrial Fusion","volume":"809","author":"Zhu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.12659\/MSM.900487","article-title":"Upregulated MiR-17 Regulates Hypoxia-Mediated Human Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis by Targeting Mitofusin 2","volume":"22","author":"Lu","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41419-022-05091-2","article-title":"FUNDC1-Mediated Mitophagy and HIF1\u03b1 Activation Drives Pulmonary Hypertension during Hypoxia","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"L545","DOI":"10.1152\/ajplung.00303.2013","article-title":"Glucose-6-Phosphate Dehydrogenase Plays a Critical Role in Hypoxia-Induced CD133+ Progenitor Cells Self-Renewal and Stimulates Their Accumulation in the Lungs of Pulmonary Hypertensive Rats","volume":"307","author":"Chettimada","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"L287","DOI":"10.1152\/ajplung.00229.2014","article-title":"Hypoxia-Induced Glucose-6-Phosphate Dehydrogenase Overexpression and -Activation in Pulmonary Artery Smooth Muscle Cells: Implication in Pulmonary Hypertension","volume":"308","author":"Chettimada","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pupt.2005.08.002","article-title":"Role of Pentose Phosphate Pathway-Derived NADPH in Hypoxic Pulmonary Vasoconstriction","volume":"19","author":"Gupte","year":"2006","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/2045-8932.97606","article-title":"Metabolomic Analysis of Bone Morphogenetic Protein Receptor Type 2 Mutations in Human Pulmonary Endothelium Reveals Widespread Metabolic Reprogramming","volume":"2","author":"Fessel","year":"2012","journal-title":"Pulm. Circ."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"L508","DOI":"10.1152\/ajplung.00165.2020","article-title":"Glucose-6-Phosphate Dehydrogenase Deficiency Contributes to Metabolic Abnormality and Pulmonary Hypertension","volume":"320","author":"Varghese","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1096\/fj.00-0893fje","article-title":"Glucose-6-Phosphate Dehydrogenase Deficiency Promotes Endothelial Oxidant Stress and Decreases Endothelial Nitric Oxide Bioavailability","volume":"15","author":"Leopold","year":"2001","journal-title":"FASEB J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"695","DOI":"10.15252\/emmm.201404511","article-title":"Genetic and Hypoxic Alterations of the MicroRNA-210-ISCU1\/2 Axis Promote Iron-Sulfur Deficiency and Pulmonary Hypertension","volume":"7","author":"White","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1165\/rcmb.2019-0065OC","article-title":"Rats with a Human Mutation of NFU1 Develop Pulmonary Hypertension","volume":"62","author":"Niihori","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ajhg.2011.10.005","article-title":"A Fatal Mitochondrial Disease Is Associated with Defective NFU1 Function in the Maturation of a Subset of Mitochondrial Fe-S Proteins","volume":"89","author":"Tort","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fgene.2015.00123","article-title":"Clinical, Biochemical, and Genetic Spectrum of Seven Patients with NFU1 Deficiency","volume":"6","author":"Ahting","year":"2015","journal-title":"Front. Genet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1165\/rcmb.2019-0309ED","article-title":"NFU1, Iron-Sulfur Biogenesis, and Pulmonary Arterial Hypertension: A (Metabolic) Shift in Our Thinking","volume":"62","author":"Culley","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1161\/CIRCULATIONAHA.118.035889","article-title":"BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension","volume":"139","author":"Yu","year":"2019","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e136459","DOI":"10.1172\/JCI136459","article-title":"Frataxin Deficiency Promotes Endothelial Senescence in Pulmonary Hypertension","volume":"131","author":"Culley","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.119.316398","article-title":"Long range Endocrine Delivery of Circulating MiR-210 to Endothelium Promotes Pulmonary Hypertension","volume":"127","author":"Zhao","year":"2020","journal-title":"Circ. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2009.08.015","article-title":"MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1\/2","volume":"10","author":"Chan","year":"2009","journal-title":"Cell Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00109-009-0524-6","article-title":"The Inhibition of Pyruvate Dehydrogenase Kinase Improves Impaired Cardiac Function and Electrical Remodeling in Two Models of Right Ventricular Hypertrophy: Resuscitating the Hibernating Right Ventricle","volume":"88","author":"Piao","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1126\/scitranslmed.aao4583","article-title":"Inhibition of Pyruvate Dehydrogenase Kinase Improves Pulmonary Arterial Hypertension in Genetically Susceptible Patients","volume":"9","author":"Michelakis","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1096\/fj.09-131664","article-title":"Dichloroacetate Treatment Partially Regresses Established Pulmonary Hypertension in Mice with SM22alpha-Targeted Overexpression of the Serotonin Transporter","volume":"23","author":"Guignabert","year":"2009","journal-title":"FASEB J."},{"key":"ref_87","first-page":"6973636","article-title":"Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via P38 Signaling","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","article-title":"Metabolic Regulation of Immune Responses","volume":"32","author":"Ganeshan","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2013.03.019","article-title":"Long-Term Safety of Dichloroacetate in Congenital Lactic Acidosis","volume":"109","author":"Abdelmalak","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.molcel.2011.10.015","article-title":"Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism","volume":"44","author":"Hitosugi","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-018-06376-x","article-title":"Alpha-Enolase Regulates the Malignant Phenotype of Pulmonary Artery Smooth Muscle Cells via the AMPK-Akt Pathway","volume":"9","author":"Dai","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1073\/pnas.1821401116","article-title":"PFKFB3-Mediated Endothelial Glycolysis Promotes Pulmonary Hypertension","volume":"116","author":"Cao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/bph.15339","article-title":"Mice with a Specific Deficiency of Pfkfb3 in Myeloid Cells Are Protected from Hypoxia-Induced Pulmonary Hypertension","volume":"178","author":"Wang","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijcard.2018.03.104","article-title":"3-Bromopyruvate Reverses Hypoxia-Induced Pulmonary Arterial Hypertension through Inhibiting Glycolysis: In Vitro and in Vivo Studies","volume":"266","author":"Chen","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1164\/rccm.200512-1976OC","article-title":"Cyclosporin A Inhibits Hypoxia-Induced Pulmonary Hypertension and Right Ventricle Hypertrophy","volume":"174","author":"Koulmann","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4070\/kcj.2018.0061","article-title":"Protective Effect of Right Ventricular Mitochondrial Damage by Cyclosporine A in Monocrotaline-Induced Pulmonary Hypertension","volume":"48","author":"Lee","year":"2018","journal-title":"Korean Circ. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"95240","DOI":"10.1172\/jci.insight.95240","article-title":"Pulmonary Arterial Hypertension Treatment with Carvedilol for Heart Failure: A Randomized Controlled Trial","volume":"2","author":"Farha","year":"2017","journal-title":"JCI Insight"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1465-9921-8-15","article-title":"Rapamycin Attenuates Hypoxia-Induced Pulmonary Vascular Remodeling and Right Ventricular Hypertrophy in Mice","volume":"8","author":"Paddenberg","year":"2007","journal-title":"Respir. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1165\/rcmb.2012-0429OC","article-title":"Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension","volume":"48","author":"Houssaini","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/674311","article-title":"Everolimus in Patients with Severe Pulmonary Hypertension: A Safety and Efficacy Pilot Trial","volume":"3","author":"Seyfarth","year":"2013","journal-title":"Pulm. Circ."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41598-020-58334-7","article-title":"Functional Analysis of Molecular and Pharmacological Modulators of Mitochondrial Fatty Acid Oxidation","volume":"10","author":"Ma","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00109-011-0804-9","article-title":"Therapeutic Inhibition of Fatty Acid Oxidation in Right Ventricular Hypertrophy: Exploiting Randle\u2019s Cycle","volume":"90","author":"Fang","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/682427","article-title":"Effects of Ranolazine on Exercise Capacity, Right Ventricular Indices, and Hemodynamic Characteristics in Pulmonary Arterial Hypertension: A Pilot Study","volume":"5","author":"Khan","year":"2015","journal-title":"Pulm. Circ."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cardfail.2020.10.006","article-title":"Ranolazine Improves Right Ventricular Function in Patients with Precapillary Pulmonary Hypertension: Results from a Double-Blind, Randomized, Placebo-Controlled Trial","volume":"27","author":"Han","year":"2021","journal-title":"J. Card. Fail."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Verdejo, H.E., Rojas, A., L\u00f3pez-Crisosto, C., Baraona, F., Gabrielli, L., Maracaja-Coutinho, V., Chiong, M., Lavandero, S., and Castro, P.F. (2023). Effects of Trimetazidine on Right Ventricular Function and Ventricular Remodeling in Patients with Pulmonary Artery Hypertension: A Randomised Controlled Trial. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041571"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e019091","DOI":"10.1161\/JAHA.120.019091","article-title":"Simultaneous Pharmacologic Inhibition of Yes-Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic-Co-Glycolic) Acid-Encapsulated Microparticles Improves Pulmonary Hypertension","volume":"10","author":"Acharya","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Valuparampil Varghese, M., James, J., Eccles, C.A., Niihori, M., Rafikova, O., and Rafikov, R. (2020). Inhibition of Anaplerosis Attenuated Vascular Proliferation in Pulmonary Arterial Hypertension. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020443"},{"key":"ref_108","first-page":"PA3059","article-title":"Impact of treprostinil on dynamin-related protein 1 (DRP1) and mitochondrial fragmentation in pulmonary arterial hypertension (PAH)","volume":"52","author":"Taanman","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/labinvest.3700361","article-title":"Heme Oxygenase-1 Mediates the Protective Effects of Rapamycin in Monocrotaline-Induced Pulmonary Hypertension","volume":"86","author":"Zhou","year":"2006","journal-title":"Lab. Investig."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"48925","DOI":"10.18632\/oncotarget.10596","article-title":"Mitochondrial Transplantation Attenuates Hypoxic Pulmonary Hypertension","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/j.jtcvs.2020.09.061","article-title":"Commentary: Small Packages, Big Questions: Mitochondrial Transplantation in a Preclinical Model of Pulmonary Arterial Hypertension","volume":"163","author":"Charles","year":"2022","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/j.jtcvs.2020.08.014","article-title":"Transplantation of Viable Mitochondria Improves Right Ventricular Performance and Pulmonary Artery Remodeling in Rats with Pulmonary Arterial Hypertension","volume":"163","author":"Hsu","year":"2022","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"L641","DOI":"10.1152\/ajplung.00484.2021","article-title":"Reviewing the Suitability of Mitochondrial Transplantation as Therapeutic Approach for Pulmonary Hypertension in the Era of Personalized Medicine","volume":"322","author":"Maarman","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9572\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:46:18Z","timestamp":1760125578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":114,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms24119572"],"URL":"https:\/\/doi.org\/10.3390\/ijms24119572","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}